NewsMedium impact
LLY Looks 18.8% Undervalued on GF Value™
gurufocus.com·5 days ago·Global·1 min read
Rigense market context
News
No image available. Showing a neutral Rigense placeholder.
On August 26, 2026, Eli Lilly and Co (NYSE: LLY) announced compelling study results showing that prolonged use of its weight loss drug Zepbound significantly re
Related news
News
ANF Looks 3.2% Undervalued on GF Value™
gurufocus.com
News
BBWI Looks 48.4% Undervalued on GF Value™ with Strong Dividend Yield
gurufocus.com
News
Is EA Overvalued? DCF Says Worth $49
gurufocus.com
News
DCI Looks 13.7% Overvalued on GF Value™ as Growth Prospects Brighten
gurufocus.com
News
META Looks 32.4% Undervalued on GF Value™ as Insider Selling Continues
gurufocus.com
News
ZH Looks 17.3% Undervalued on GF Value™ Despite Unprofitable Status
gurufocus.com